Commonly used mouse models of osteosarcoma
- PMID: 16837208
- DOI: 10.1016/j.critrevonc.2006.03.006
Commonly used mouse models of osteosarcoma
Abstract
Osteosarcoma is the commonest primary tumour of bone and the second highest cause of cancer-related death in the paediatric age group. Little is known of the aetiology of human osteosarcoma and lesser still of the various interactions that occur between host and tumour cells that govern growth and progression of osteosarcoma in vivo. Although numerous osteosarcoma cell lines have been established and characterized in vitro, some as far back as in the 1960s, there is a scarcity of reliable and reproducible in vivo animal models that mimics all aspects of the human condition at the temporal, physiological and histopathological level, hence, making the accurate testing of therapeutic strategies difficult. Given that osteosarcoma is a disease that affects young people and better disease management strategies are essential, development of a robust human osteosarcoma model is long overdue.
Similar articles
-
Development of chondrosarcoma animal models for assessment of adjuvant therapy.ANZ J Surg. 2009 May;79(5):327-36. doi: 10.1111/j.1445-2197.2009.04884.x. ANZ J Surg. 2009. PMID: 19566512 Review.
-
Animal models of osteosarcoma.Expert Rev Anticancer Ther. 2010 Aug;10(8):1327-38. doi: 10.1586/era.10.107. Expert Rev Anticancer Ther. 2010. PMID: 20735317 Review.
-
The interleukin-11 receptor alpha as a candidate ligand-directed target in osteosarcoma: consistent data from cell lines, orthotopic models, and human tumor samples.Cancer Res. 2009 Mar 1;69(5):1995-9. doi: 10.1158/0008-5472.CAN-08-4845. Epub 2009 Feb 24. Cancer Res. 2009. PMID: 19244100
-
Fluorovisualization effect of acridine orange on mouse osteosarcoma.Anticancer Res. 2000 Sep-Oct;20(5A):3019-24. Anticancer Res. 2000. PMID: 11062717
-
A bioluminescent orthotopic mouse model of human osteosarcoma that allows sensitive and rapid evaluation of new therapeutic agents In vivo.In Vivo. 2009 Sep-Oct;23(5):661-8. In Vivo. 2009. PMID: 19779098
Cited by
-
Establishment of orthotopic osteosarcoma animal models in immunocompetent rats through muti-rounds of in-vivo selection.BMC Cancer. 2024 Jun 7;24(1):703. doi: 10.1186/s12885-024-12361-z. BMC Cancer. 2024. PMID: 38849717 Free PMC article.
-
In vitro and in vivo antitumor effects of the VO-chrysin complex on a new three-dimensional osteosarcoma spheroids model and a xenograft tumor in mice.J Biol Inorg Chem. 2016 Dec;21(8):1009-1020. doi: 10.1007/s00775-016-1397-0. Epub 2016 Oct 1. J Biol Inorg Chem. 2016. PMID: 27696106
-
In vivo pharmacological evaluation and efficacy study of methotrexate-encapsulated polymer-coated layered double hydroxide nanoparticles for possible application in the treatment of osteosarcoma.Drug Deliv Transl Res. 2017 Apr;7(2):259-275. doi: 10.1007/s13346-016-0351-6. Drug Deliv Transl Res. 2017. PMID: 28050892
-
Genetically engineered mouse models and human osteosarcoma.Clin Sarcoma Res. 2012 Oct 4;2(1):19. doi: 10.1186/2045-3329-2-19. Clin Sarcoma Res. 2012. PMID: 23036272 Free PMC article.
-
Extracellular Vesicles from Highly Metastatic Osteosarcoma Cells Induce Pro-Tumorigenic Macrophage Phenotypes.Adv Biol (Weinh). 2024 Jun;8(6):e2300577. doi: 10.1002/adbi.202300577. Epub 2024 Apr 10. Adv Biol (Weinh). 2024. PMID: 38596830
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical